Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Trellis Bioscience Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10852
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trellis Bioscience Inc (Trellis) is a drug development company that discovers and develops human antibody therapeutics for the treatment of bacterial and viral infectious diseases and cancer indications. The company’s clinical candidate includes TRL1068, which targets and disintegrates bacterial biofilm. The company develops CellSpot technology to find rare human antibodies that are identified and recovered from human blood cells. Its antibodies can be applied in the treatment of infectious disease such as respiratory syncytial virus, cytomegalovirus, auto-immune diseases, Influenza and cancer. The company provides pipeline of therapies in bacterial, viral, and cancer indications. It operates through government and philanthropic institutions, biotech and pharma companies. Trellis is headquartered in Menlo Park, California, the US.

Trellis Bioscience Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trellis Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Trellis Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 11
Trellis Bioscience Enters Into Agreement With Open Monoclonal Technology To Discover Human Therapeutic Antibodies 12
Licensing Agreements 13
ContraFect Enters Into Licensing Agreement With Trellis 13
ContraFect Amends Licensing Agreement With Trellis 14
Trellis Bioscience Inc – Key Competitors 15
Trellis Bioscience Inc – Key Employees 16
Trellis Bioscience Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts 2
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trellis Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trellis Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Trellis Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 11
Trellis Bioscience Enters Into Agreement With Open Monoclonal Technology To Discover Human Therapeutic Antibodies 12
ContraFect Enters Into Licensing Agreement With Trellis 13
ContraFect Amends Licensing Agreement With Trellis 14
Trellis Bioscience Inc, Key Competitors 15
Trellis Bioscience Inc, Key Employees 16

List of Figures
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Trellis Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Trellis Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rockwell Medical Inc (RMTI)-医療機器分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • eClinicalWorks LLC:企業の戦略的SWOT分析
    eClinicalWorks LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Polski Koncern Naftowy Orlen SA (PKN):石油・ガス:M&Aディール及び事業提携情報
    Summary Polski Koncern Naftowy Orlen SA (PKN Orlen) is an integrated oil and gas company. It explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. Its product portf …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務情報
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Prismic Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a pharmaceutical company that provides research and development of prescription drugs which has unique safety profiles. The company develops drugs for inflammatory diseases and oxidative stress disorders. It pipeline products are used …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • Companhia Energetica de Minas Gerais SA (CMIG4):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Minas Gerais SA (CEMIG) is an integrated energy utility. Through its subsidiaries and jointly-controlled investees, the company has presence in the electricity vertical. The company produces power from biomass, wind, solar, hydro, fossil, and nuclear sources; and proc …
  • Hutchison China Meditech Ltd
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Graham Holdings Company:企業の戦略・SWOT・財務情報
    Graham Holdings Company - Strategy, SWOT and Corporate Finance Report Summary Graham Holdings Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chime Communications Limited:企業のM&A・事業提携・投資動向
    Chime Communications Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chime Communications Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • juwi AG:電力:M&Aディール及び事業提携情報
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • Papa John’s International, Inc.:戦略・SWOT・企業財務分析
    Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Qube Holdings Ltd:企業の戦略・SWOT・財務情報
    Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Origin Energy Limited:戦略・SWOT・企業財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Companhia Energetica de Sao Paulo (CESP6)-エネルギー分野:企業M&A・提携分析
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company generates energy from hydro source. CESP owns power plants at at Rio Paran, Rio Paraibuna, and Rio J …
  • Aker Solutions ASA (AKSO):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker Solutions ASA (Aker Solutions) is a global provider of engineering, design, production systems and services to the oil and gas industry. The company offers subsea production equipment and offshore field design, ranging from concept studies and front-end engineering to subsea production …
  • The GPT Group:企業の戦略・SWOT・財務情報
    The GPT Group - Strategy, SWOT and Corporate Finance Report Summary The GPT Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆